RESULTS OF A PHASE-IV STUDY CARRIED OUT WITH ACIPIMOX IN TYPE-II DIABETIC-PATIENTS WITH CONCOMITANT HYPERLIPOPROTEINEMIA

被引：19
作者：
LAVEZZARI, M [1 ]
MILANESI, G [1 ]
OGGIONI, E [1 ]
PAMPARANA, F [1 ]
机构：
[1] FARMITALIA CARLO ERBA SPA, FUNZ MED ITALIA, DEPT MED, VIA C IMBONATI 24, I-20159 MILAN, ITALY
来源：
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH | 1989年 / 17卷 / 04期
关键词：
D O I：
10.1177/030006058901700411
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：373 / 380
页数：8
相关论文
共 13 条
[1]   ACIPIMOX IN THE TREATMENT OF PATIENTS WITH HYPERLIPEMIA - A DOUBLE-BLIND TRAIL [J].
BALL, MJ ;
VELLA, M ;
RECHLASS, JPD ;
JONES, DB ;
STIRLING, C ;
MANN, JI ;
GALTON, D .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 31 (02) :201-204
[2]  
BEUMONT JL, 1970, B WORLD HEALTH ORGAN, V43, P891
[3]   PLASMA-LIPID LOWERING ACTIVITY OF ACIPIMOX IN PATIENTS WITH TYPE-II AND TYPE-IV HYPERLIPOPROTEINEMIA - RESULTS OF A MULTICENTER TRIAL [J].
CREPALDI, G ;
AVOGARO, P ;
DESCOVICH, GC ;
DIPERRI, T ;
POSTIGLIONE, A ;
SIRTORI, CR ;
STRANO, A ;
VENTURA, S ;
MUSATTI, L .
ATHEROSCLEROSIS, 1988, 70 (1-2) :115-121
[4]   PHARMACOEPIDEMIOLOGY .5. POSTMARKETING SURVEILLANCE METHODOLOGIES [J].
EDLAVITCH, SA .
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1988, 22 (01) :68-78
[5]   INHIBITION OF LIPOLYSIS BY NICOTINIC-ACID AND BY ACIPIMOX [J].
FUCCELLA, LM ;
GOLDANIGA, G ;
LOVISOLO, P ;
MAGGI, E ;
MUSATTI, L ;
MANDELLI, V ;
SIRTORI, CR .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (06) :790-795
[6]   EFFECT OF NICOTINIC ACID IN DIABETES MELLITUS [J].
MOLNAR, GD ;
MCGUCKIN, WF ;
ACHOR, RWP ;
ROSEVEAR, JW ;
BERGE, KG .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1964, 13 (02) :181-+
[7]  
POLLACK H, 1962, DIABETES, V11, P144
[8]   THE CONTRIBUTION OF EPIDEMIOLOGY TO THE STUDY OF DRUGS .1. [J].
PORTA, MS ;
HARTZEMA, AG .
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1987, 21 (09) :741-747
[9]  
REGAL H, 1984, DRUG EXP CLIN RES, V10, P621
[10]   REDUCED TRIGLYCERIDEMIA AND INCREASED HIGH-DENSITY LIPOPROTEIN CHOLESTEROL LEVELS AFTER TREATMENT WITH ACIPIMOX, A NEW INHIBITOR OF LIPOLYSIS [J].
SIRTORI, CR ;
GIANFRANCESCHI, G ;
SIRTORI, M ;
BERNINI, F ;
DESCOVICH, G ;
MONTAGUTI, U ;
FUCCELLA, LM ;
MUSATTI, L .
ATHEROSCLEROSIS, 1981, 38 (3-4) :267-271
12